Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - pamidronate disodium, quantity: 6 mg - injection, concentrated - excipient ingredients: mannitol; water for injections; sodium hydroxide; phosphoric acid - treatment of conditions associated with increased osteoclast activity predominantly lytic bone metastases from breast cancer and advanced multiple myeloma. acute management of tumour-induced hypercalcaemia (hypercalcaemia of malignancy). treatment of symptomatic paget's disease of bone.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - pamidronate disodium, quantity: 3 mg - injection, concentrated - excipient ingredients: mannitol; phosphoric acid; water for injections; sodium hydroxide - treatment of conditions associated with increased osteoclast activity predominantly lytic bone metastases from breast cancer and advanced multiple myeloma. acute management of tumour-induced hypercalcaemia (hypercalcaemia of malignancy). treatment of symptomatic paget's disease of bone.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - pamidronate disodium, quantity: 3 mg - injection, concentrated - excipient ingredients: phosphoric acid; mannitol; sodium hydroxide; water for injections - treatment of conditions associated with increased osteoclast activity: predominantly lytic bone metastases from breast cancer and advanced multiple myeloma. acute management of tumour-induced hypercalcaemia (hypercalcaemia of malignancy). treatment of symptomatic paget's disease of bone.

Ireland - English - HPRA (Health Products Regulatory Authority)

neomed technology ltd - pamidronate disodium - concentrate for soln for inf - 3mg/ml mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

neomed technology ltd - pamidronate disodium - concentrate for soln for inf - 9mg/ml mg/ml

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hospira benelux bv-srl - disodium pamidronate 6 mg/ml - eq. pamidronic acid 2,53 mg/ml - concentrate for solution for infusion - 6 mg/ml - pamidronate disodium 6 mg/ml - pamidronic acid

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hospira benelux bv-srl - disodium pamidronate 3 mg/ml - eq. pamidronic acid 2,53 mg/ml - concentrate for solution for infusion - 3 mg/ml - pamidronate disodium 3 mg/ml - pamidronic acid

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hospira benelux bv-srl - disodium pamidronate 3 mg/ml - eq. pamidronic acid 2,53 mg/ml - concentrate for solution for infusion - 3 mg/ml - pamidronate disodium 3 mg/ml - pamidronic acid

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hospira benelux bv-srl - disodium pamidronate 9 mg/ml - eq. pamidronic acid 2,53 mg/ml - concentrate for solution for infusion - 9 mg/ml - pamidronate disodium 9 mg/ml - pamidronic acid

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - disodium pamidronate 3 mg/ml - eq. pamidronic acid 2,527 mg/ml - concentrate for solution for infusion - 3 mg/ml - pamidronate disodium 3 mg/ml - pamidronic acid